🇺🇸 AMGN — Amgen Inc.

Healthcare Compra
← Volver

Precio actual

437,23 USD

Máx. histórico

447,03

10 días

Caída desde máximo

-2,19%

Rango 52 semanas

269,77 – 447,03

Variación hoy

-1,55%

Cierre anterior

444,12

Rango de hoy

435,01 – 441,66

Volumen hoy

1.615.172

Información
Nombre completo
Amgen Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
31.500
PER ⓘ
27,17 (puede no estar actualizado)
Dividend yield
2,27% (puede no estar actualizado)
Precio objetivo analistas
389,69 USD (puede no estar actualizado)
Primera cotización
17/06/1983
Precio actualizado
hace 2 días
Sobre la empresa

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Dividendos repartidos Total últimos 12 meses: 9,9400 USD · Yield: 2,27%
Fecha de pago Importe por participación
16/11/2022 1,9400 USD
17/08/2022 1,9400 USD
16/05/2022 1,9400 USD
14/02/2022 1,9400 USD
15/11/2021 1,7600 USD
16/08/2021 1,7600 USD
14/05/2021 1,7600 USD
11/02/2021 1,7600 USD
13/11/2020 1,6000 USD
14/08/2020 1,6000 USD
15/05/2020 1,6000 USD
13/02/2020 1,6000 USD
14/11/2019 1,4500 USD
14/08/2019 1,4500 USD
16/05/2019 1,4500 USD
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
24/05/2019 172,62 173,77 171,09 171,28 -0,48% 1,55% 2.417.100
23/05/2019 171,34 173,06 170,49 172,11 +0,47% 1,50% 2.902.500
22/05/2019 169,35 172,05 168,58 171,30 +0,95% 2,05% 2.615.500
21/05/2019 169,77 170,02 168,53 169,69 +0,77% 0,88% 2.249.300
20/05/2019 168,68 170,40 168,15 168,39 -0,89% 1,33% 2.144.300
17/05/2019 169,27 171,24 169,11 169,91 -0,01% 1,26% 2.266.600
16/05/2019 169,40 172,02 169,34 169,92 +0,03% 1,58% 2.716.200
15/05/2019 167,23 170,60 166,30 169,87 +1,23% 2,57% 2.860.200
14/05/2019 167,68 169,72 167,30 167,81 +0,13% 1,44% 2.525.300
13/05/2019 169,24 169,60 167,17 167,60 -2,47% 1,44% 3.371.800
10/05/2019 172,46 172,46 168,44 171,85 -0,59% 2,33% 2.942.300
09/05/2019 171,24 173,18 169,44 172,87 +0,42% 2,18% 2.854.400
08/05/2019 173,50 175,50 171,70 172,15 -0,99% 2,19% 3.368.400
07/05/2019 175,14 176,41 172,50 173,87 -1,80% 2,23% 2.797.000
06/05/2019 175,49 177,24 173,88 177,06 -0,14% 1,91% 2.735.000
03/05/2019 176,93 177,77 176,47 177,31 +0,46% 0,73% 2.944.500
02/05/2019 176,06 178,30 174,30 176,50 +0,20% 2,27% 3.014.000
01/05/2019 175,40 178,50 171,25 176,14 -1,77% 4,13% 6.109.100
30/04/2019 181,63 182,04 177,88 179,32 -1,02% 2,29% 3.963.000
29/04/2019 181,45 182,47 179,59 181,17 -0,17% 1,59% 2.662.500
26/04/2019 180,70 181,85 180,03 181,47 +0,55% 1,01% 2.445.400
25/04/2019 177,08 181,02 175,92 180,48 +1,22% 2,88% 2.453.700
24/04/2019 180,14 180,83 178,26 178,30 -0,81% 1,43% 2.711.600
23/04/2019 176,94 180,65 175,75 179,76 +1,93% 2,77% 3.471.700
22/04/2019 177,10 177,57 174,87 176,36 -0,63% 1,52% 3.215.800
18/04/2019 183,24 183,49 176,85 177,47 -2,74% 3,62% 8.266.600
17/04/2019 188,35 188,74 181,53 182,47 -2,97% 3,83% 5.242.100
16/04/2019 192,27 192,57 187,44 188,05 -1,65% 2,67% 2.727.300
15/04/2019 191,84 193,18 189,85 191,20 -0,11% 1,74% 2.038.300
12/04/2019 193,02 193,48 190,79 191,42 -0,36% 1,39% 2.060.800